HACD2 Promotes Pancreatic Cancer Progression by Enhancing PKM2 Dissociation From PRKN in a Dehydratase‐Independent Manner

Abstract 3‐Hydroxyacyl‐CoA dehydratase 2 (HACD2), an obesity‐related gene involved in the elongation of long‐chain fatty acids, is highly expressed in pancreatic cancer (PC) and is associated with patient prognosis. Interestingly, the study reveals that HACD2 mediated the proliferation of PC cells i...

Full description

Saved in:
Bibliographic Details
Main Authors: Xuanning Chu, Jinyu Zhao, Yuting Shen, Qi Feng, Changlin Zhou, Lingman Ma, Yiran Zhou
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202407942
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849723919271985152
author Xuanning Chu
Jinyu Zhao
Yuting Shen
Qi Feng
Changlin Zhou
Lingman Ma
Yiran Zhou
author_facet Xuanning Chu
Jinyu Zhao
Yuting Shen
Qi Feng
Changlin Zhou
Lingman Ma
Yiran Zhou
author_sort Xuanning Chu
collection DOAJ
description Abstract 3‐Hydroxyacyl‐CoA dehydratase 2 (HACD2), an obesity‐related gene involved in the elongation of long‐chain fatty acids, is highly expressed in pancreatic cancer (PC) and is associated with patient prognosis. Interestingly, the study reveals that HACD2 mediated the proliferation of PC cells in a dehydratase‐independent manner, affecting the downstream glycolytic pathway. Mechanistically, HACD2 promotes PC cells proliferation by binding to E3 ubiquitin‐protein ligase parkin (PRKN) and enhancing pyruvate kinase PKM (PKM2) dissociation from PRKN, resulting in reduced ubiquitination of PKM2 and increased dimerization of PKM2, which subsequently promote c‐Myc expression and tumor growth. Moreover, HACD2 overexpression‐induced PC growth is mitigated by knockdown of PKM2 or overexpression of PRKN. Furthermore, the weight loss drug orlistat, which potentially binds to HACD2, disrupted the interaction between HACD2 and PRKN and further increased the ubiquitination of PKM2. Therefore, this study elucidates the mechanism by which the obesity‐related gene HACD2 regulates PC cells proliferation through a noncanonical signaling pathway, which may provide a potential new target and strategy for the individualized clinical treatment of PC.
format Article
id doaj-art-04627f08e09e42a4a8ae58ff28662df6
institution DOAJ
issn 2198-3844
language English
publishDate 2025-03-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj-art-04627f08e09e42a4a8ae58ff28662df62025-08-20T03:10:53ZengWileyAdvanced Science2198-38442025-03-011210n/an/a10.1002/advs.202407942HACD2 Promotes Pancreatic Cancer Progression by Enhancing PKM2 Dissociation From PRKN in a Dehydratase‐Independent MannerXuanning Chu0Jinyu Zhao1Yuting Shen2Qi Feng3Changlin Zhou4Lingman Ma5Yiran Zhou6School of Life Science and Technology China Pharmaceutical University Nanjing Jiangsu 211198 ChinaSchool of Life Science and Technology China Pharmaceutical University Nanjing Jiangsu 211198 ChinaSchool of Life Science and Technology China Pharmaceutical University Nanjing Jiangsu 211198 ChinaSchool of Life Science and Technology China Pharmaceutical University Nanjing Jiangsu 211198 ChinaSchool of Life Science and Technology China Pharmaceutical University Nanjing Jiangsu 211198 ChinaSchool of Life Science and Technology China Pharmaceutical University Nanjing Jiangsu 211198 ChinaDepartment of General Surgery Pancreatic Disease Center Ruijin Hospital Shanghai Jiaotong University School of Medicine 197 Ruijin Er Road Shanghai 200025 ChinaAbstract 3‐Hydroxyacyl‐CoA dehydratase 2 (HACD2), an obesity‐related gene involved in the elongation of long‐chain fatty acids, is highly expressed in pancreatic cancer (PC) and is associated with patient prognosis. Interestingly, the study reveals that HACD2 mediated the proliferation of PC cells in a dehydratase‐independent manner, affecting the downstream glycolytic pathway. Mechanistically, HACD2 promotes PC cells proliferation by binding to E3 ubiquitin‐protein ligase parkin (PRKN) and enhancing pyruvate kinase PKM (PKM2) dissociation from PRKN, resulting in reduced ubiquitination of PKM2 and increased dimerization of PKM2, which subsequently promote c‐Myc expression and tumor growth. Moreover, HACD2 overexpression‐induced PC growth is mitigated by knockdown of PKM2 or overexpression of PRKN. Furthermore, the weight loss drug orlistat, which potentially binds to HACD2, disrupted the interaction between HACD2 and PRKN and further increased the ubiquitination of PKM2. Therefore, this study elucidates the mechanism by which the obesity‐related gene HACD2 regulates PC cells proliferation through a noncanonical signaling pathway, which may provide a potential new target and strategy for the individualized clinical treatment of PC.https://doi.org/10.1002/advs.202407942HACD2pancreatic cancerPKM2PRKNubiquitination
spellingShingle Xuanning Chu
Jinyu Zhao
Yuting Shen
Qi Feng
Changlin Zhou
Lingman Ma
Yiran Zhou
HACD2 Promotes Pancreatic Cancer Progression by Enhancing PKM2 Dissociation From PRKN in a Dehydratase‐Independent Manner
Advanced Science
HACD2
pancreatic cancer
PKM2
PRKN
ubiquitination
title HACD2 Promotes Pancreatic Cancer Progression by Enhancing PKM2 Dissociation From PRKN in a Dehydratase‐Independent Manner
title_full HACD2 Promotes Pancreatic Cancer Progression by Enhancing PKM2 Dissociation From PRKN in a Dehydratase‐Independent Manner
title_fullStr HACD2 Promotes Pancreatic Cancer Progression by Enhancing PKM2 Dissociation From PRKN in a Dehydratase‐Independent Manner
title_full_unstemmed HACD2 Promotes Pancreatic Cancer Progression by Enhancing PKM2 Dissociation From PRKN in a Dehydratase‐Independent Manner
title_short HACD2 Promotes Pancreatic Cancer Progression by Enhancing PKM2 Dissociation From PRKN in a Dehydratase‐Independent Manner
title_sort hacd2 promotes pancreatic cancer progression by enhancing pkm2 dissociation from prkn in a dehydratase independent manner
topic HACD2
pancreatic cancer
PKM2
PRKN
ubiquitination
url https://doi.org/10.1002/advs.202407942
work_keys_str_mv AT xuanningchu hacd2promotespancreaticcancerprogressionbyenhancingpkm2dissociationfromprkninadehydrataseindependentmanner
AT jinyuzhao hacd2promotespancreaticcancerprogressionbyenhancingpkm2dissociationfromprkninadehydrataseindependentmanner
AT yutingshen hacd2promotespancreaticcancerprogressionbyenhancingpkm2dissociationfromprkninadehydrataseindependentmanner
AT qifeng hacd2promotespancreaticcancerprogressionbyenhancingpkm2dissociationfromprkninadehydrataseindependentmanner
AT changlinzhou hacd2promotespancreaticcancerprogressionbyenhancingpkm2dissociationfromprkninadehydrataseindependentmanner
AT lingmanma hacd2promotespancreaticcancerprogressionbyenhancingpkm2dissociationfromprkninadehydrataseindependentmanner
AT yiranzhou hacd2promotespancreaticcancerprogressionbyenhancingpkm2dissociationfromprkninadehydrataseindependentmanner